Article Information
PubMed
Print ISSN
Online ISSN
History
- Received April 9, 2012
- Accepted July 12, 2012
- Published online September 17, 2012.
Article Versions
- Earlier version (July 12, 2012 - 07:52).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2012 by The American Society for Pharmacology and Experimental Therapeutics
Author Information
- Mosun A. Ayan-Oshodi,
- Brian A. Willis,
- William F. Annes,
- Stephen L. Lowe,
- Stuart Friedrich,
- Amparo de la Peña,
- Wei Zhang,
- Thomas Brown,
- Stephen D. Wise, and
- Stephen D. Hall
- Address correspondence to:
M.A. Ayan-Oshodi, Clinical Pharmacology, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, IN 46285. E-mail: mayan{at}lilly.com
This work was previously presented in poster form: Ayan-Oshodi MA, Willis BA, Annes WF, Lowe SL, Friedrich S, de la Peña A, Zhang W, and Hall SD (2011) The contribution of CYP3A enzymes to the single and multiple dose oral clearance of the autoinducer semagacestat. Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics; 2011 March 2–5; Dallas, TX. Eli Lilly and Company, Indianapolis, IN.